-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Depreciation history and growth rate for Q3 2024.
- BriaCell Therapeutics Corp. Depreciation for the quarter ending October 31, 2024 was $22.8K.